Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
03/22/2007 | WO2007033221A2 Methods and compositions for inhibition of immune responses |
03/22/2007 | WO2007032634A1 A method for production of mature natural killer cell |
03/22/2007 | WO2007032555A1 Method of controlling decomposition of protein by tetracycline antibiotic |
03/22/2007 | WO2007032373A1 Analysis method on risk of tumor formation |
03/22/2007 | WO2007032255A1 T-cell receptor and nucleic acid encoding the receptor |
03/22/2007 | WO2007032224A1 Cultured cell sheet and method for preparation thereof |
03/22/2007 | WO2007032160A1 Marker gene for examining hypertension |
03/22/2007 | WO2007032138A1 Method of preparing cells enriched with coenzyme q10, additive for growing cells enriched with coenzyme q10, medium enriched with coenzyme q10 and cells enriched with coenzyme q10 |
03/22/2007 | WO2007032111A1 Stress-inducible transcriptional factor originating in corn |
03/22/2007 | WO2007031867A2 A hepatitis c virus non-stru tural ns3/4a fusion gene |
03/22/2007 | WO2007031273A2 Artificial immune-reconstituted epidermis equivalents |
03/22/2007 | WO2007030937A2 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
03/22/2007 | WO2007030870A1 Cardiomyocyte production |
03/22/2007 | WO2007016485A3 Use of a gsk-3 inhibitor to maintain potency of cultured cells |
03/22/2007 | WO2007014455A9 Cancerous disease modifying antibodies |
03/22/2007 | WO2007001851A3 Compositions and methods for the diagnosis and treatment of tumor |
03/22/2007 | WO2006115951A3 Ubiquilin regulation of presenilin endoproteolysis, and suppression of polyglutamine-induced toxicity in cells |
03/22/2007 | WO2006069936A3 Method for producing polyunsaturated long-chain fatty acids in transgenic organisms |
03/22/2007 | WO2006067742A3 Immortalized endothelial cells |
03/22/2007 | US20070067879 Novel soybean |
03/22/2007 | US20070067878 Novel soybean |
03/22/2007 | US20070067877 Novel soybean |
03/22/2007 | US20070067875 Plants having improved growth characteristics and a method for making the same |
03/22/2007 | US20070067874 Plants which synthesize a modified starch, process for the production thereof and modified starch |
03/22/2007 | US20070067873 Modified ppase expression in sugar beet |
03/22/2007 | US20070067872 Sugar and lipid metabolism regulators in plants III |
03/22/2007 | US20070067871 Agronomically elite soybeans with high beta-conglycinin content |
03/22/2007 | US20070067869 Chemically inducible expression of biosynthetic pathways |
03/22/2007 | US20070067868 Insect resistant cotton plants and methods of detecting the same |
03/22/2007 | US20070067867 Gene cluster involved in biosynthesis of isopentenyl diphosphate in the non-mevalonate pathway of Hevea brasiliensis |
03/22/2007 | US20070067866 Gene cluster of prenyl transferase from Hevea brasiliensis |
03/22/2007 | US20070067864 Cytochrome P450 oxygenases and their uses |
03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
03/22/2007 | US20070067860 Novel culture systems for ex vivo development |
03/22/2007 | US20070067856 Therapeutic agent for NGF |
03/22/2007 | US20070067855 Production of human glycosylated proteins in transgenic insects |
03/22/2007 | US20070066812 Fibroblast growth factor homologous factor-2 and methods of use |
03/22/2007 | US20070066811 Adipocyte complement related protein zacrp3x2 |
03/22/2007 | US20070066809 Monoclonal antibodies to gastrin hormone |
03/22/2007 | US20070066805 Human tumor necrosis factor receptor |
03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
03/22/2007 | US20070066546 Compositions for the reversible thioesterification of signaling proteins and methods of using same |
03/22/2007 | US20070066524 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
03/22/2007 | US20070065943 Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof |
03/22/2007 | US20070065942 isolated from the papillary region of the human kidney; surface positive for CD133 and intracellular nestin |
03/22/2007 | US20070065941 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
03/22/2007 | US20070065940 Method of preparing basement membrane, method of constructing basement membrane specimen, reconstituted artificial tissue using the basement membrane specimen and process for producing the same |
03/22/2007 | US20070065939 Systems for detection and production of respiratory, herpes and enteric viruses |
03/22/2007 | US20070065938 Perivascular mesenchymal precursor cells |
03/22/2007 | US20070065931 use in modulation of gene expression in plant cells; use in optimizing crop traits such as nutritional value, disease resistance, herbicide resistance; agronomics |
03/22/2007 | US20070065925 Vaccine containing cell transformed with a nucleotide sequence of the genome of Porcine circovirus type B |
03/22/2007 | US20070065919 produces anti-Staphylococcus antibodies; monoclonal antibody is produced by providing a population of B-lymphocytes from a donor, immortalizing the population, separating a plurality of cells from the population to yield a first oligoclonal cell culture, culturing the the cell culture; |
03/22/2007 | US20070065912 Multiple Gene Expression including sORF Constructs and Methods with Polyproteins, Pro-Proteins, and Proteolysis |
03/22/2007 | US20070065907 Process for the production of biological substances by perfusion culturing of suspended animal cells |
03/22/2007 | US20070065904 Recombinant expression vectors for functional nav1.9 sodium channels |
03/22/2007 | US20070065875 NTB-A, a surface molecule involved in natural killer cells activity |
03/22/2007 | US20070065873 Human T2R55 taste receptor and related assays for identifying human bitter taste modulators |
03/22/2007 | US20070065871 Human T2R71 receptor and related assays for identifying human bitter taste modulators |
03/22/2007 | US20070065870 nucleic acid molecule coding for g protein-coupled recept for use in identifying modulators of taste transductance; artificial sweetners; used as additives in foods, beverages and medicinals for blocking bitter taste |
03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
03/22/2007 | US20070065829 In vitro differentiation of vascular smooth muscle cells, methods and reagents related thereto |
03/22/2007 | US20070065807 Method of preparing basement membrane, method of constructing basement membrane specimen, reconstituted artificial tissue using the basement membrane specimen and process for producing the same |
03/22/2007 | US20070065805 Cell migration assay |
03/22/2007 | US20070065803 Patterns for a skeletal system |
03/22/2007 | US20070065467 Immunostimulatory nucleic acid molecules for activating dendritic cells |
03/22/2007 | US20070065457 Circovirus sequences associated with piglet weight loss disease (PWD) |
03/22/2007 | US20070065454 Liposomal vaccine |
03/22/2007 | US20070065445 Novel cyclooxygenase variants and methods of use |
03/22/2007 | US20070065439 Antibodies against interleukin-1 beta |
03/22/2007 | US20070065430 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
03/22/2007 | US20070065425 Anti-idiotypic antibody neutralizing the inhibitor activity of a factor viii inhibitor antibody |
03/22/2007 | US20070065419 Using cultured keratin synthesizing cells as therapeutic tools in treatment of chronic injury; regenerative medicine; tissue engineering |
03/22/2007 | US20070065417 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
03/22/2007 | US20070065416 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
03/22/2007 | US20070065415 Compositions and methods for the augmentation and repair of defects in tissue |
03/22/2007 | US20070065414 Enhanced delivery of cells |
03/22/2007 | US20070065409 Use of pleiotrophin in the diagnosis, treatment and prevention of disease |
03/22/2007 | US20070065405 Uses of human Zven proteins and polynucleotides |
03/22/2007 | US20070065404 Uses of humans zven proteins and polynucleotides |
03/22/2007 | US20070065403 Uses of human Zven proteins and polynucleotides |
03/22/2007 | CA2622610A1 Fish vaccine |
03/22/2007 | CA2622575A1 Prok2 antagonists and methods of use |
03/22/2007 | CA2621407A1 Alcohol acetyl transferase gene and use thereof |
03/22/2007 | CA2619298A1 Modified antigen binding molecules with altered cell signaling activity |
03/22/2007 | CA2618429A1 A hepatitis c virus non-structural ns3/4a fusion gene |
03/21/2007 | EP1764421A2 Device for decarbonising a steel melt |
03/21/2007 | EP1764370A2 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin - 2 |
03/21/2007 | EP1764113A1 Antibodies against lung cancer, antigens and methods of use thereof for treating lung cancer |
03/21/2007 | EP1763582A2 Means and methods for controlling flowering in plants |
03/21/2007 | EP1763576A2 Ex-vivo application of solid microparticulate therapeutic agents |
03/21/2007 | EP1763538A2 Genetically engineered cells for therapeutic applications |
03/21/2007 | EP1696945A4 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
03/21/2007 | EP1578194A4 Biological assays using gradients formed in microfluidic systems |
03/21/2007 | EP1558076A4 Device and method for monitoring leukocyte migration |
03/21/2007 | EP1502108A4 Device and method for monitoring leukocyte migration |
03/21/2007 | EP1472336B1 Method and device for cultivating cells in high densities and for obtaining products from said cells |
03/21/2007 | EP1461359B1 Novel anti-igf-ir antibodies and uses thereof |
03/21/2007 | EP1397492B1 Modified and stabilized gdf propeptides and uses thereof |
03/21/2007 | EP1337850B1 Method for diagnosing a tumor in a patient determining the concentration of pibf |
03/21/2007 | EP1337629B1 Dipeptidyl peptidases |